Chinese Journal of Natural Medicines, Journal Year: 2024, Volume and Issue: 22(12), P. 1134 - 1162
Published: Dec. 1, 2024
Language: Английский
Chinese Journal of Natural Medicines, Journal Year: 2024, Volume and Issue: 22(12), P. 1134 - 1162
Published: Dec. 1, 2024
Language: Английский
Industrial Crops and Products, Journal Year: 2025, Volume and Issue: 228, P. 120902 - 120902
Published: March 25, 2025
Language: Английский
Citations
6Advanced Science, Journal Year: 2024, Volume and Issue: 11(16)
Published: Feb. 28, 2024
Abstract Traditional Chinese Medicine (TCM) is widely used in clinical practice to treat diseases related central nervous system (CNS) damage. However, the blood‐brain barrier (BBB) constitutes a significant impediment effective delivery of TCM, thus substantially diminishing its efficacy. Advances nanotechnology and applications TCM (also known as nano‐TCM) can deliver active ingredients or components across BBB targeted brain region. This review provides an overview physiological pathological mechanisms systematically classifies common CNS types nanocarriers that effectively brain. Additionally, drug strategies for nano‐TCMs utilize vivo properties vitro devices bypass cross are discussed. further focuses on application treatment various diseases. Finally, this article anticipates design strategy with higher efficiency probes their potential treating wider range
Language: Английский
Citations
12Plant Cell & Environment, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 10, 2025
ABSTRACT The efficacy of Taxol, a natural anticancer drug, in the treatment various types cancers has been certified globally. Fungal elicitors have reported as an impressive strategy for enhancing Taxol biosynthesis. We investigated effect twig age on biosynthesis and communities endophytic fungi. A negative correlation between content complexity fungal community twigs was predicted. Endogenous taxoids, similar to balancing valves, might specific controlling microbiota assembly Taxus twigs. Utilising special correlation, 11 isolates age‐associated fungi were used screen new involved Two efficient elicitors, L01 ( Guignardia ) J02 Diaporthe ), identified, increasing contents by 5.91‐ 4.83‐folds, respectively. It is confirmed that effective may be negatively correlated with tissues. Furthermore, significantly induced jasmonic acid (JA) content, speculating involvement MYC2a‐controlled JA signalling elicitor‐activated Our data revealed provided novel approach
Language: Английский
Citations
1Nature Synthesis, Journal Year: 2025, Volume and Issue: unknown
Published: April 30, 2025
Language: Английский
Citations
1Nature Plants, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 27, 2024
Language: Английский
Citations
4Biotechnology and Bioprocess Engineering, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 31, 2025
Language: Английский
Citations
0Springer eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 42
Published: Jan. 1, 2025
Language: Английский
Citations
0Clinical and Experimental Nephrology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 24, 2025
Language: Английский
Citations
0Materials Today Bio, Journal Year: 2025, Volume and Issue: 32, P. 101793 - 101793
Published: April 23, 2025
Immunotherapy shows promise for tumor control but is limited by low response rates. Paclitaxel (PTX) induces immunogenic cell death (ICD), yet conventional delivery systems face challenges like drug loading and insufficient intracellular accumulation, reducing ICD efficacy. Small-molecule self-assembled PTX nanoparticles offer a promising solution due to high dose delivery. In this study, was conjugated with phenylboronic acid (PBA) form the derivative PTX-PBA, which spontaneously fructose into (PTX-PBA-Fru NPs). These exhibited uniform size of 107.8 ± 2.9 nm, PDI 0.064 0.042, zeta potential -12.2 0.9 mV, spherical morphology. 4T1 tumor-bearing mice, PTX-PBA-Fru NPs significantly enhanced inhibition (p < 0.001) increased body weight 0.05). No allergic reactions in healthy Balb/c mice maximum tolerated intravenous reached 200 mg/kg, underscoring its favorable safety profile NPs. The effects induced NPs, when combined immunomodulator resiquimod (R848), elicited robust anti-tumor immune response. This combination therapy effectively remodeled immunosuppressive microenvironment achieved 37.5 % eradication rate. Moreover, it established long-term memory, providing protection against re-challenge. novel formulation demonstrates strong effects, safety, clinical R848-based immunotherapy.
Language: Английский
Citations
0Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown
Published: April 25, 2025
Language: Английский
Citations
0